Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Sandoz and Henlius Enter Strategic Partnership to Develop Up to 10 Biosimilars.
Aug 17, 2026
Contract Type
partnership
BaselHealth CareMedical
Description
Sandoz has announced a major collaboration agreement with Shanghai Henlius Biotech, Inc. to develop and commercialize up to 10 biosimilars. This partnership will bolster Sandoz's portfolio and expand patient access to essential biosimilar therapies globally.
Company Information
Company
Sandoz
Location
Basel, Basel City, Switzerland
About
Sandoz is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients. 22,000 people of more than 100 nationalities work together to bring Sandoz medicines to some 500 million patients worldwide, generating substantial global healthcare savings and an even larger total social impact.